zoledronic acid has been researched along with tretinoin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Carcas, AJ; Cordoba, R; Hernandez-Navarro, F; Lei, SH; Lopez de la Guia, A; Ramirez, E; Sanjurjo, MJ | 1 |
| Atmaca, H; Karabulut, B; Karaca, B; Kisim, A; Sezgin, C; Uslu, R; Uzunoglu, S | 1 |
| Atmaca, H; Cakar, B; Karabulut, B; Karaca, B; Kisim, A; Muslu, U; Uslu, R; Uzunoglu, S; Varol, U | 1 |
1 review(s) available for zoledronic acid and tretinoin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for zoledronic acid and tretinoin
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid.
Topics: Adult; Antineoplastic Agents; Diphosphonates; Drug Interactions; Drug Therapy, Combination; Humans; Hypercalcemia; Imidazoles; Itraconazole; Leukemia, Promyelocytic, Acute; Male; Treatment Outcome; Tretinoin; Zoledronic Acid | 2008 |
Regulation of apoptosis-related molecules by synergistic combination of all-trans retinoic acid and zoledronic acid in hormone-refractory prostate cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Caspase 7; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diphosphonates; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation, Neoplastic; Hormones; Humans; Imidazoles; Male; Prostatic Neoplasms; Receptors, Tumor Necrosis Factor; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Tretinoin; Zoledronic Acid | 2011 |
Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Proliferation; Diphosphonates; Drug Synergism; Female; Gene Expression Profiling; Humans; Imidazoles; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tretinoin; Tumor Cells, Cultured; Zoledronic Acid | 2010 |